Search research articles
Contact Us
Filters
Showing results (1-10 of 83) with videos related to
Page
of 9
Sort By:
Thrombosis and Haemostasis
|
June 30, 1981
Platelet activation in myeloproliferative disorders
S Cortelazzo, P Viero, T Barbui
Thrombosis and Haemostasis
|
July 29, 1984
Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
P Viero, S Cortelazzo, T Barbui
JAMA
|
January 3, 1986
IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters
G Finazzi, S Cortelazzo, P Viero, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1986
Generation of procoagulant activity by hairy cells in response to endotoxin and phorbol esters
P Viero, S Cortelazzo, T Barbui, et al.
The Science of the Total Environment
|
November 25, 2023
Beyond flood hazard. Mapping the loss probability of pedestrians to improve risk estimation and communication
Tommaso Lazzarin, Albert S Chen, Daniele P Viero
La Ricerca in Clinica E in Laboratorio
|
January 1, 1981
Spectrum of platelet aggregation abnormalities in myeloproliferative diseases
S Cortelazzo, P Viero, R Bassan, et al.
Haematologica
|
July 1, 1987
Hereditary dysfunctional protein C (protein C "Bergamo II") diagnosed by a rapid assay
G Finazzi, P Viero, S Cortelazzo, et al.
Thrombosis and Haemostasis
|
October 29, 1982
Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases
P Viero, S Cortelazzo, R Bassan, et al.
Haemostasis
|
January 1, 1986
Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: deficiency of an aspirin-independent mechanism?
P Viero, S Cortelazzo, T Barbui, et al.
British Journal of Haematology
|
September 1, 1984
Myelokathexis: a rare form of chronic benign granulocytopenia
R Bassan, P Viero, B Minetti, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 83) with videos related to
Sort By:
Page
of 9
Thrombosis and Haemostasis
|
June 30, 1981
Platelet activation in myeloproliferative disorders
S Cortelazzo, P Viero, T Barbui
Thrombosis and Haemostasis
|
July 29, 1984
Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
P Viero, S Cortelazzo, T Barbui
JAMA
|
January 3, 1986
IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters
G Finazzi, S Cortelazzo, P Viero, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1986
Generation of procoagulant activity by hairy cells in response to endotoxin and phorbol esters
P Viero, S Cortelazzo, T Barbui, et al.
The Science of the Total Environment
|
November 25, 2023
Beyond flood hazard. Mapping the loss probability of pedestrians to improve risk estimation and communication
Tommaso Lazzarin, Albert S Chen, Daniele P Viero
La Ricerca in Clinica E in Laboratorio
|
January 1, 1981
Spectrum of platelet aggregation abnormalities in myeloproliferative diseases
S Cortelazzo, P Viero, R Bassan, et al.
Haematologica
|
July 1, 1987
Hereditary dysfunctional protein C (protein C "Bergamo II") diagnosed by a rapid assay
G Finazzi, P Viero, S Cortelazzo, et al.
Thrombosis and Haemostasis
|
October 29, 1982
Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases
P Viero, S Cortelazzo, R Bassan, et al.
Haemostasis
|
January 1, 1986
Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: deficiency of an aspirin-independent mechanism?
P Viero, S Cortelazzo, T Barbui, et al.
British Journal of Haematology
|
September 1, 1984
Myelokathexis: a rare form of chronic benign granulocytopenia
R Bassan, P Viero, B Minetti, et al.
Page
of 9